SYNNF yields 434.78% · PFE yields 6.13%● Live data
📍 SYNNF pulled ahead of the other in Year 1
Combined, SYNNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYNNF + PFE for your $10,000?
Symphony International Holdings Limited is a private equity and venture capital firm specializing in investments in early stage, management buy-outs, emerging growth, management buy-ins, restructurings, special situations, and the provision of growth capital for later-stage development and expansion. It also invests in real estate development. The firm typically invests in innovative and high-growth consumer businesses, new economy, primarily in the education, hospitality, lifestyle logistics, new economy, healthcare, healthcare related services, luxury branded real estate, hospitality and lifestyle sectors. It prefers to make long-term direct investments in the Asia Pacific region with a focus on Australia, India, Indonesia, Malaysia, Singapore, Taiwan, Thailand, Vietnam and Sri Lanka. The firm seeks to achieve control and majority positions in partnership with the management of the acquired business. It seeks to be the lead or sole investor. Symphony International Holdings Limited was founded in 2004 and is based in British Virgin Islands.
Full SYNNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.